Navigation Links
Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medical's Board of Directors
Date:11/20/2012

WESTMINSTER, Colo., Nov. 20, 2012 /PRNewswire/ -- Surefire Medical, Inc., a developer of innovative high-efficiency infusion systems for the interventional radiology and interventional oncology markets, today announced the appointment of Gene McGrevin to its Board of Directors.

"Gene McGrevin is an excellent medical device strategist with a very strong background in sales, marketing and in running public companies.  As Surefire Medical transitions to full-scale commercialization in the U.S., Europe and Asia, Gene's addition to the Surefire Board is both timely and a great gain for the company," said Surefire Medical Board chairman Norman Weldon.

With 25 years of senior management positions in the medical industry at companies including Johnson & Johnson and Kimberly-Clark Corporation, Mr. McGrevin also was instrumental in the expansion and sale of several medical startups.  They include PetNet Pharmaceuticals (sold to Siemens), Microtek Medical Holdings (sold to EcoLabs), and Medivance (sold to C.R. Bard).  

"In my judgment Surefire Medical has the three key ingredients for success in the marketplace," McGrevin said.  "The company has innovative technology that physicians are quickly adopting due to its proven clinical impact on patient care.  It has strong IP.  And with higher embolization efficiency, Surefire Medical's infusion devices are cost-effective as well as clinically relevant."

Mr. McGrevin also serves on the Boards of the Yerkes Primate Center, Real Time Medical Data and HydroDynamics.

"We are delighted that Gene has joined the Board of Directors of Surefire Medical," said Jim Chomas, Chief Executive Officer.  "Gene's extensive experience in strategic market development brings additional valuable perspective to our Board.  I look forward to his contributions as we advance Surefire Medical's growth strategy."

Mr. McGrevin holds an MBA from the University of Pennsylvania's Wharton School.  He earned a BA in economics at the University of Pittsburgh.

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop a platform of innovative infusion systems for the interventional radiology market.  Surefire's infusion catheters precisely deliver embolic agents through a novel expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow.  The Surefire Infusion System increases embolization efficiency, minimizes reflux and reduces damage to healthy tissue.  For more information, please visit www.surefiremedical.com.


'/>"/>
SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Christopher Mennone Joins Surefire Medical Team As International Business Director
2. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
3. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
4. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
5. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
6. Boston Scientific to Acquire BridgePoint Medical, Inc.
7. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
8. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
9. Solta Medical, Inc. Closes Public Offering of Common Stock
10. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
11. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
Breaking Medicine Technology:
(Date:6/24/2017)... ... June 24, 2017 , ... ... at the Sheraton Erie Bayfront and Erie Convention Center on June 8-10. ... exhibits, a student quiz bowl, award and scholarship presentations, and professional networking. ...
(Date:6/23/2017)... ... 23, 2017 , ... The Rhode Island Quality Institute (RIQI) ... and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate care ... and Dashboards provide near real-time data about patients admitted to and/or discharged from ...
(Date:6/23/2017)... (PRWEB) , ... June 24, 2017 , ... Studies show ... significantly reduce the risk of visual loss in these patients. , But how often ... diet, or smoking cessation to patients at risk of or with early symptoms of ...
(Date:6/23/2017)... ... ... Everybody has their own personal preference when it comes to pornography. Some ... don't like it at all. FindaTopDoc took a look at what makes people attracted ... readers a taste of their deepest, darkest fantasies and has the ability to help ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):